The Shandong Federation of Light Industry Enterprises officially announced the 2026 Shandong Provincial Small and Medium Enterprise Innovation R&D Center accreditation list. Shandong New-Line Biotechnology Co., Ltd. was officially accredited as a "Shandong Provincial SME Innovation R&D Center". This recognition highlights New-Line's R&D capabilities, proprietary bacteriophage library exceeding 60,000 pathogen strains, and strong track record in agricultural biological transition.

From October 10 to 11, 2026, Shandong New-Line Biotechnology Co., Ltd. successfully convened its Q3 2026 Sales Review and Q4 Strategic Deployment Conference. The company celebrated record-shattering performance in the third quarter, reaching an annual peak with September sales volume breaking all historical records. Featuring in-depth guidance from the PhD research team, frontline market case studies, and strategic deployment for the fourth quarter, the conference solidified the enterprise's technological moat in green antimicrobial phage solutions.

Comprehensive review of New-Line Bio's international market outreach and collaborative achievements at VIV Shanghai 2026.

Shandong New-Line Biotechnology Co., Ltd. successfully convened its 2026 Mid-Year Strategic Conference and corporate team retreat, strengthening unity and driving execution.

Shandong New-Line Biotechnology Co., Ltd. has been officially designated as a Provincial 'Specialized, Refined, Differential and Innovative' (SRDI) SME by the Department of Industry and Information Technology.

Shandong New-Line Biotechnology Co., Ltd. has been officially awarded the prestigious title of "Specialized, Refined, Differential and Innovative" (SRDI) Small and Medium Enterprise by the Shandong Provincial Department of Industry and Information Technology, affirming our technological leadership in agricultural bacteriophage manufacturing.

Shandong New-Line Bio and CAS ISA officially signed a comprehensive strategic cooperation agreement to advance joint research in livestock phage applications.

Shandong New-Line Biotechnology Co., Ltd. was officially selected into the prestigious 'Shandong Manufacturing · Qilu Premium Brands' registry, recognizing exceptional quality and independent innovation.

Shandong New-Line Biotechnology Co., Ltd. hosted its 2025 Annual Gala, reviewing milestone achievements in bacteriophage R&D and outlining ambitious strategic growth targets for the future.

The 'New-Line Cup 2025 Weicheng Entrepreneurship Competition' co-organized by Shandong New-Line Biotechnology Co., Ltd. concluded with great success, fostering innovation and talent in regional biotechnology.